IRVINE, Calif. & AMSTERDAM--(BUSINESS WIRE)--New breast cancer research highlighting the value of Agendia’s MammaPrint® and BluePrint® genomic tests will be presented in 10 scientific posters at the upcoming 2015 San Antonio Breast Cancer Symposium (SABCS).
